On June 6, 2016, Aikang Guobin, a medical check-up service provider listed in the US, announced that the board of directors of the company had received a non-binding offer from the private equity investment institution Yunfeng Fund, hoping to use 20-per depository certificates. The US$25 acquisition of all issued shares of Ikang Guobin.
The market originally thought that Yunfeng Fund was only a new buyer of this privatization acquisition war. As a result, Yunfeng Fund played the role of the terminator of this acquisition war. In the following two days, the two people who had been stalemate in the privatization of the Ikang Guobin, the founder and CEO of Aikang Guobin, and the number one competitor of Ikang Guobin, were healthy, and successively announced the withdrawal of the privatization of the Ikang Guobin. .
Ma Yun’s entry into the end of the year of “I love each otherâ€
In fact, the ceiling of the quotation proposed by Yunfeng Fund ($25/ADS) is about 24.5%-55.6% higher than the quotation of IKEA’s privatization proposal for the first time since August 28 last year. Compared with the proposed privatization offer (US$25/ADS) proposed by the US Health Day on the 6th, there is no further price increase:
In August 2015, Zhang Kangang, chairman of Aikang Guobin, and Fangyuan Capital, a private equity fund, launched a privatization offer for Aikang Guobin at a price of US$17.8/ADS.
On November 29, 2015, Jiangsu Sanyou, who had just completed the asset reorganization with Mei Nian Health, announced that it would jointly send a “non-binding†privatization offer to Aikang Guobin in conjunction with Ping An, Sequoia and Taiping Capital. The offer price is $22/ADS, which is 23.6% higher than the offer of the Zhang Ligang buyer group.
In February 2015, Ikang Guobin offered a “poison pill plan†in an attempt to block the rapid “offensive†of the health of the US in a way that would increase the difficulty and cost of the acquisition. Zhang Ligang claimed that "the determination to complete privatization with Fangyuan Capital will not change, and will not sell the shares it owns or controls to any third party."
On December 15, 2015, the US announced a price increase again, raising the offer price to $23.5/ADS.
On January 5, 2016, Ikang Guobin just announced that the privatization consortium led by Zhang Ligang, the company's chairman, had joined the new members, including Alibaba and China Life.
On January 6, 2016, the US made another offer to increase the purchase price to US$25/ADS, which is about 40.4% higher than the proposed price of the Zhang Ligang buyer group.
You can see that both sides of the camp are very powerful: the Year of Health has gathered together Ping An, Sequoia, Taiping, and the capital of VC and PE, while Aikang Guobin has gathered industries and insurances such as Alibaba and China Life. capital. It is particularly noteworthy that Ma Yun has now quietly entered the game with Alibaba.
In the following six months, the privatization battle entered a stalemate period. The two sides did not propose new acquisition offers, but the battlefield seemed to extend from capital to a broader level. Ikang Guobin initiated three lawsuits against the health of the United States:
On February 24th, Ikang Guobin issued a notice saying that Aikang Guobin’s former health management personnel, Yuan Yuanmao, Mei Nian Da Health Industry (Group) Co., Ltd., Mei Nian Da Health Industry Holdings Co., Ltd., Guangzhou Mei Nian Medical Outpatient Department Co., Ltd. and Guangzhou Mei Nian Da Health Medical Technology Co., Ltd. filed a civil lawsuit for infringement of trade secrets and demanded compensation of 50 million yuan for all losses.
On March 10th, Ikang Guobin issued a public statement, announcing the real name report, the US Health Year, and the illegal acquisition of Ci Ming's medical examination without anti-monopoly review, violating the Anti-Monopoly Law.
On May 23, on the day of the resumption of the US Health Day, Ikang Guobin once again held a press conference and said that he received an anonymous report from the insiders of the US Health Center. Wang Haifeng, the general manager of the US-based software company Ikon took away the source code after leaving the company, and a few months later, highly similar software was used for the health check-up center in the United States.
Just as the battle between the two sides became increasingly hot, Ma Yun’s Yunfeng Fund ended it all.
BAT officially entered the medical examination industry "Internet + physical examination" curtain will be opened
4D Cog 21G60mm,Pdo Thread Korea,Fio De Pdo,Minerva Premium Pdo Thread Lifting
Qingdao Beautiful Skin Biotechnology Co., Ltd , https://www.hafilleresthetic.com